Medicinal Products

Loquen XR 200 mg tablete s produljenim oslobađanjem

Name Loquen XR 200 mg tablete s produljenim oslobađanjem
Marketing Authorisation Number HR-H-324298177
Active Substance quetiapinum
Pharmaceutical Form tableta s produljenim oslobađanjem
Strength 200 mg
Packaging [MA Number for Packaging] 10 tableta u blisteru, u kutiji  [HR-H-324298177-01]
20 tableta u blisteru, u kutiji  [HR-H-324298177-02]
30 tableta u blisteru, u kutiji  [HR-H-324298177-03]
50 tableta u blisteru, u kutiji  [HR-H-324298177-04]
50 tableta u u blisteru s jediničnom dozom, u kutiji  [HR-H-324298177-05]
56 tableta u blisteru, u kutiji  [HR-H-324298177-06]
60 tableta u blisteru, u kutiji  [HR-H-324298177-07]
90 tableta u blisteru, u kutiji  [HR-H-324298177-08]
100 tableta u blisteru, u kutiji  [HR-H-324298177-09]
60 tableta u bočici, u kutiji  [HR-H-324298177-10]
Manufacturer Teva Pharma S.L.U., Zaragoza, Španjolska;
Teva UK Ltd., Eastbourne, East Sussex, Ujedinjeno Kraljevstvo;
Teva Czech Industries s.r.o., Opava-Komarov, Češka;
Merckle GmbH, Blaubeuren, Baden-Wuerttemberg, Njemačka;
Teva Gyogyszergyar Zrt., Debrecen, Mađarska;
Pharmachemie B.V., Haarlem, Nizozemska;
Adamed Sp. z o.o., Czosnow, Poljska;
Teva Operations Poland Sp. z o.o., Krakow, Poljska
Marketing Authorisation Holder Pliva Hrvatska d.o.o., Prilaz baruna Filipovića 25, Zagreb
Marketing Authorisation Date 08.05.2019
MA Period of Validity unlimited
Classification Number UP/I-530-09/18-02/163
Registration Number 381-12-01/38-19-03
Composition svaka tableta sadrži 200 mg kvetiapina u obliku kvetiapinfumarata
Prescription na recept
Type of prescription ponovljivi recept
Distribution u ljekarni
Advertising to general public zabranjeno
ATC Code N05AH04
Medicinal product marketed in the Croatia Da
SmPC download
PL download
Public Assessment Report download
Educational materials
for healthcare professionals
Podsjetnik o važnosti nadziranja metaboličkih parametara tijekom liječenja kvetiapinom, verzija 2
Back